The weekly litigation news digest is live. Subscribe now

IP Verse

Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof - EP3401335

The patent EP3401335 was granted to Genentech on Jun 30, 2021. The application was filed on Jan 28, 2009 under application number EP18157419A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3401335

GENENTECH
Application Number
EP18157419A
Filing Date
Jan 28, 2009
Status
Granted And Under Opposition
May 28, 2021
Publication Date
Jun 30, 2021
External Links
Slate, Register, Google Patents

Patent Summary

A composition for treating HER2 positive cancers that contains a main species HER2 antibody that binds to domain II of HER2 and acidic variants of that antibody. The main species antibody is the predominant antibody in the composition. The acidic variants can have modifications like deamidation, disulfide reduction, or glycosylation changes. The main species antibody and variants all bind to HER2 and have similar pharmacokinetics.

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_COA_0000914/2025Nov 27, 2025Organon, Organon HeistAppeal
UPC_COA_0000913/2025Nov 27, 2025Organon, Organon HeistAppeal
UPC_CFI_408/2025May 6, 2025F Hoffmann LA Roche, GenentechGeneric
UPC_CFI_407/2025May 6, 2025F Hoffmann LA Roche, GenentechGeneric

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ABEL & IMRAYMar 30, 2022ABEL & IMRAYADMISSIBLE
EUROPEAN OPPOSITIONSMar 30, 2022KILBURN & STRODEADMISSIBLE
STRAWMANMar 28, 2022GILL JENNINGS & EVERYWITHDRAWN
POHLMANMar 22, 2022POHLMANADMISSIBLE
HEXALNov 8, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORFADMISSIBLE
HEXALNov 8, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE

Patent Citations (140) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0003089
DESCRIPTIONEP0404097
DESCRIPTIONEP0599274
DESCRIPTIONEP0659439
DESCRIPTIONUS2002004587
DESCRIPTIONUS2003157108
DESCRIPTIONUS2004093621
DESCRIPTIONUS2005101617
DESCRIPTIONUS2006013819
DESCRIPTIONUS2006018899
DESCRIPTIONUS2006088523
DESCRIPTIONUS2007020261
DESCRIPTIONUS3773919
DESCRIPTIONUS4485045
DESCRIPTIONUS4544545
DESCRIPTIONUS4676980
DESCRIPTIONUS4816567
DESCRIPTIONUS4933294
DESCRIPTIONUS4943533
DESCRIPTIONUS4968603
DESCRIPTIONUS5013556
DESCRIPTIONUS5183884
DESCRIPTIONUS5208020
DESCRIPTIONUS5212290
DESCRIPTIONUS5229275
DESCRIPTIONUS5264586
DESCRIPTIONUS5401638
DESCRIPTIONUS5457105
DESCRIPTIONUS5475001
DESCRIPTIONUS5480968
DESCRIPTIONUS5500362
DESCRIPTIONUS5545807
DESCRIPTIONUS5565332
DESCRIPTIONUS5567610
DESCRIPTIONUS5571894
DESCRIPTIONUS5573905
DESCRIPTIONUS5587458
DESCRIPTIONUS5589369
DESCRIPTIONUS5591669
DESCRIPTIONUS5616582
DESCRIPTIONUS5641869
DESCRIPTIONUS5641870
DESCRIPTIONUS5654307
DESCRIPTIONUS5677171
DESCRIPTIONUS5679683
DESCRIPTIONUS5712374
DESCRIPTIONUS5714586
DESCRIPTIONUS5731168
DESCRIPTIONUS5739277
DESCRIPTIONUS5747498
DESCRIPTIONUS5760041
DESCRIPTIONUS5766863
DESCRIPTIONUS5770599
DESCRIPTIONUS5772997
DESCRIPTIONUS5773001
DESCRIPTIONUS5783186
DESCRIPTIONUS5804396
DESCRIPTIONUS5821337
DESCRIPTIONUS5824311
DESCRIPTIONUS5837234
DESCRIPTIONUS5866572
DESCRIPTIONUS5891996
DESCRIPTIONUS6002008
DESCRIPTIONUS6084095
DESCRIPTIONUS6140332
DESCRIPTIONUS6194551
DESCRIPTIONUS6235883
DESCRIPTIONUS6242195
DESCRIPTIONUS6265410
DESCRIPTIONUS6339142
DESCRIPTIONUS6344455
DESCRIPTIONUS6344459
DESCRIPTIONUS6391874
DESCRIPTIONUS6399602
DESCRIPTIONUS6455534
DESCRIPTIONUS6521620
DESCRIPTIONUS6528624
DESCRIPTIONUS6538124
DESCRIPTIONUS6596726
DESCRIPTIONUS6602684
DESCRIPTIONUS6602863
DESCRIPTIONUS6713484
DESCRIPTIONUS6949245
DESCRIPTIONWO0042072
DESCRIPTIONWO0100245
DESCRIPTIONWO03011878
DESCRIPTIONWO03086467
DESCRIPTIONWO9100360
DESCRIPTIONWO9105264
DESCRIPTIONWO9220373
DESCRIPTIONWO9308829
DESCRIPTIONWO9311161
DESCRIPTIONWO9316185
DESCRIPTIONWO9321232
DESCRIPTIONWO9321319
DESCRIPTIONWO9400136
DESCRIPTIONWO9404690
DESCRIPTIONWO9411026
DESCRIPTIONWO9422478
DESCRIPTIONWO9603397
DESCRIPTIONWO9616673
DESCRIPTIONWO9630347
DESCRIPTIONWO9633978
DESCRIPTIONWO9633980
DESCRIPTIONWO9640210
DESCRIPTIONWO9700271
DESCRIPTIONWO9704801
DESCRIPTIONWO9730087
DESCRIPTIONWO9738731
DESCRIPTIONWO9738983
DESCRIPTIONWO9802463
DESCRIPTIONWO9814451
DESCRIPTIONWO9817797
DESCRIPTIONWO9843960
DESCRIPTIONWO9845479
DESCRIPTIONWO9850038
DESCRIPTIONWO9850433
DESCRIPTIONWO9858964
DESCRIPTIONWO9906378
DESCRIPTIONWO9906396
DESCRIPTIONWO9909016
DESCRIPTIONWO9919488
DESCRIPTIONWO9922764
DESCRIPTIONWO9924037
DESCRIPTIONWO9951642
OPPOSITIONWO0100245
OPPOSITIONWO2004008099
OPPOSITIONWO2006033700
OPPOSITIONWO2006044908
OPPOSITIONWO2006063042
OPPOSITIONWO2006078307
OPPOSITIONWO2006091693
OPPOSITIONWO2006096861
OPPOSITIONWO2007013950
OPPOSITIONWO2007145862
OPPOSITIONWO2009099829
OPPOSITIONWO2014172371
OPPOSITIONWO9957134
SEARCHEP1308455
SEARCHWO2006033700

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents